223 related articles for article (PubMed ID: 35044940)
1. Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh.
Islam SRU; Akther T; Sultana S; Deb P; Ghosh AK; Nasif MAO; Bhuiyan AH; Jahan M; Nessa A; Munshi SU; Tabassum S
J Infect Dev Ctries; 2021 Dec; 15(12):1833-1837. PubMed ID: 35044940
[TBL] [Abstract][Full Text] [Related]
2. Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting.
Mourya DT; Yadav PD; Majumdar TD; Chauhan DS; Katoch VM
Indian J Med Res; 2014 Aug; 140(2):171-83. PubMed ID: 25297350
[TBL] [Abstract][Full Text] [Related]
3. Application of Biosafety Principles in Laboratory Analysis of Clinical Samples from Patients with COVID-19.
Hussain Gardezi SA; Ikram A
J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S48-S51. PubMed ID: 32515375
[TBL] [Abstract][Full Text] [Related]
4. Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.
Wang K; Zhu X; Xu J
Health Secur; 2020; 18(3):232-236. PubMed ID: 32522074
[TBL] [Abstract][Full Text] [Related]
5. Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.
Lippi G; Adeli K; Ferrari M; Horvath AR; Koch D; Sethi S; Wang CB
Clin Chem Lab Med; 2020 Jun; 58(7):1053-1062. PubMed ID: 32396137
[TBL] [Abstract][Full Text] [Related]
6. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.
Joseph T; Phyu S; Se-Thoe SY; Chu JJH
Methods Mol Biol; 2022; 2452():441-464. PubMed ID: 35554920
[TBL] [Abstract][Full Text] [Related]
7. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis.
Mourya DT; Sapkal G; Yadav PD; M Belani SK; Shete A; Gupta N
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):172-176. PubMed ID: 32242878
[TBL] [Abstract][Full Text] [Related]
8. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.
Reifel KM; Swan BK; Jellison ER; Ambrozak D; Baijer J; Nguyen R; Monard S; Lyon G; Fontes B; Perfetto SP
Cytometry A; 2020 Jul; 97(7):674-680. PubMed ID: 32488957
[TBL] [Abstract][Full Text] [Related]
9. Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent.
Kaufer AM; Theis T; Lau KA; Gray JL; Rawlinson WD
Pathology; 2020 Dec; 52(7):790-795. PubMed ID: 33070960
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for various laboratory sections in view of COVID-19: Recommendations from the Indian Association of Pathologists and Microbiologists.
Misra V; Agrawal R; Kumar H; Kar A; Kini U; Poojary A; Chakrabarti I; Rai S; Singhal A; Shankar SV; Iyengar JN
Indian J Pathol Microbiol; 2020; 63(3):350-357. PubMed ID: 32769321
[TBL] [Abstract][Full Text] [Related]
11. A survey of laboratory biosafety and protective measures in blood transfusion departments during the COVID-19 pandemic.
Liu H; Liu L; Zhang J; Shang X; Chen S; Li X; Gui R; Huang R
Vox Sang; 2021 Jul; 116(6):682-691. PubMed ID: 33529377
[TBL] [Abstract][Full Text] [Related]
12. Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects.
Li L; Gu J; Shi X; Gong E; Li X; Shao H; Shi X; Jiang H; Gao X; Cheng D; Guo L; Wang H; Shi X; Wang P; Zhang Q; Shen B
Clin Infect Dis; 2005 Sep; 41(6):815-21. PubMed ID: 16107979
[TBL] [Abstract][Full Text] [Related]
13. Biosafety Concerns During the Collection, Transportation, and Processing of COVID-19 Samples for Diagnosis.
Karthik K; Aravindh Babu RP; Dhama K; Chitra MA; Kalaiselvi G; Alagesan Senthilkumar TM; Raj GD
Arch Med Res; 2020 Oct; 51(7):623-630. PubMed ID: 32948378
[TBL] [Abstract][Full Text] [Related]
14. Biosafety during a pandemic: shared resource laboratories rise to the challenge.
Aspland AM; Douagi I; Filby A; Jellison ER; Martinez L; Shinko D; Smith AL; Tang VA; Thornton S
Cytometry A; 2021 Jan; 99(1):68-80. PubMed ID: 33289290
[TBL] [Abstract][Full Text] [Related]
15. Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey.
Loh TP; Horvath AR; Wang CB; Koch D; Adeli K; Mancini N; Ferrari M; Hawkins R; Sethi S; Lippi G;
Clin Chem Lab Med; 2020 Aug; 58(9):1441-1449. PubMed ID: 32549122
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus disinfection in histopathology.
Henwood AF
J Histotechnol; 2020 Jun; 43(2):102-104. PubMed ID: 32116147
[TBL] [Abstract][Full Text] [Related]
17. General biosafety measures for laboratory environments, outpatient clinics, medical centers, and veterinary hospitals during the SARS-CoV-2 pandemic.
Ulsenheimer BC; Pereira DIB; Dos Santos HF; von Laer AE; Tonin AA; da Costa MM; Sangioni LA; de Avila Botton S
Braz J Microbiol; 2022 Sep; 53(3):1715-1721. PubMed ID: 35352318
[TBL] [Abstract][Full Text] [Related]
18. Biosafety Requirements for Autopsies of Patients with COVID-19: Example of a BSL-3 Autopsy Facility Designed for Highly Pathogenic Agents.
Loibner M; Langner C; Regitnig P; Gorkiewicz G; Zatloukal K
Pathobiology; 2021; 88(1):37-45. PubMed ID: 33296902
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.
Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S
Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436
[TBL] [Abstract][Full Text] [Related]
20. Establishment of COVID-19 testing laboratory in resource-limited settings: challenges and prospects reported from Ethiopia.
Abera A; Belay H; Zewude A; Gidey B; Nega D; Dufera B; Abebe A; Endriyas T; Getachew B; Birhanu H; Difabachew H; Mekonnen B; Legesse H; Bekele F; Mekete K; Seifu S; Sime H; Yemanebrhan N; Tefera M; Amare H; Beyene B; Tsige E; Kebede A; Tasew G; Tollera G; Abate E; Woyessa A; Assefa A
Glob Health Action; 2020 Dec; 13(1):1841963. PubMed ID: 33200686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
